92 related articles for article (PubMed ID: 2769997)
1. [Influence of the diameter of the drug carriers for accumulation to tumors].
Murota H; Goto A; Unno K
Nihon Rinsho; 1989 Jun; 47(6):1363-8. PubMed ID: 2769997
[No Abstract] [Full Text] [Related]
2. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
[No Abstract] [Full Text] [Related]
3. Characterization and pharmacokinetics of a novel pirarubicin liposome powder.
Cong W; Liu Q; Chen X; Gao R; Lu J; Wang Y; Luo G
Drug Dev Ind Pharm; 2010 Oct; 36(10):1186-94. PubMed ID: 20515395
[TBL] [Abstract][Full Text] [Related]
4. [Controlled administration of antineoplastic drugs].
Oborotova NA
Antibiot Khimioter; 1991 Oct; 36(10):47-50. PubMed ID: 1805698
[No Abstract] [Full Text] [Related]
5. [Targeting technology utilizing magnetic microparticulate system for cancer therapy].
Morimoto Y; Natsume H
Nihon Rinsho; 1998 Mar; 56(3):649-56. PubMed ID: 9549351
[TBL] [Abstract][Full Text] [Related]
6. Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP
Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery in cancer using liposomes.
Dass CR
Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of an anti-cancer agent via steroid coupled liposomes.
Mishra PK; Gulbake A; Jain A; Vyas SP; Jain SK
Drug Deliv; 2009 Nov; 16(8):437-47. PubMed ID: 19839788
[TBL] [Abstract][Full Text] [Related]
9. [Targeting of anti-cancer drugs with nano-sized carrier system].
Yokoyama M; Okano T
Nihon Rinsho; 1998 Dec; 56(12):3227-34. PubMed ID: 9883646
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticulate systems in drug delivery and targeting.
Kreuter J
J Drug Target; 1995; 3(3):171-3. PubMed ID: 8705247
[No Abstract] [Full Text] [Related]
11. Microspheres and nonspherical particles for embolization.
Laurent A
Tech Vasc Interv Radiol; 2007 Dec; 10(4):248-56. PubMed ID: 18572137
[TBL] [Abstract][Full Text] [Related]
12. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
[TBL] [Abstract][Full Text] [Related]
13. [A study on the targeting collect character of ferromagnetic drug carrier particles in microvasculature].
Li X; Guo P; Chen Y; Xiong P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):533-7. PubMed ID: 20649013
[TBL] [Abstract][Full Text] [Related]
14. [Studies on preparation and characteristics of cisplatin chitosan microspheres].
Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
Yao Xue Xue Bao; 1996; 31(4):300-5. PubMed ID: 9208650
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of high molecular weight agents.
Cassidy J; Newell DR; Wedge SR; Cummings J
Cancer Surv; 1993; 17():315-41. PubMed ID: 8137346
[TBL] [Abstract][Full Text] [Related]
16. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
[TBL] [Abstract][Full Text] [Related]
17. Physical mechanisms and methods employed in drug delivery to tumors.
Besić E
Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
[TBL] [Abstract][Full Text] [Related]
18. Antivascular and antitumor activities of liposome-associated drugs.
Straubinger RM; Arnold RD; Zhou R; Mazurchuk R; Slack JE
Anticancer Res; 2004; 24(2A):397-404. PubMed ID: 15152936
[TBL] [Abstract][Full Text] [Related]
19. [Targeting to tumor site by the conjugate of antitumor drug with synthetic polymer].
Hirano T; Ohashi S; Todoroki T; Inaba M; Tsukagoshi S
Nihon Rinsho; 1989 Jun; 47(6):1412-6. PubMed ID: 2770002
[No Abstract] [Full Text] [Related]
20. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
